269 related articles for article (PubMed ID: 3008927)
1. Evidence for opiate action at the brain receptors for thyrotropin-releasing hormone.
Bhargava HN; Das S
Brain Res; 1986 Mar; 368(2):262-7. PubMed ID: 3008927
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of two kappa-opiate agonists, U-50,488H and U-69,593, on the binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to rat spinal cord and amygdala membranes.
Rahmani NH; Gulati A; Bhargava HN
Pharmacology; 1991; 43(3):156-62. PubMed ID: 1663623
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of [3H][3-MeHis2]thyrotropin releasing hormone recognition sites in the rat brain by tifluadom, a kappa opiate receptor agonist.
Das S; Bhargava HN
Neuropharmacology; 1987 Aug; 26(8):1141-6. PubMed ID: 2889163
[TBL] [Abstract][Full Text] [Related]
4. Unidirectional interaction between thyrotropin releasing hormone and opiates at the level of their brain receptors.
Das S; Bhargava HN
Gen Pharmacol; 1987; 18(1):99-102. PubMed ID: 3030873
[TBL] [Abstract][Full Text] [Related]
5. Stereoselectivity of kappa-opiate receptor ligands in inhibiting the binding of [3H][3-MeHis2]thyrotrophin releasing hormone to brain membranes.
Bhargava HN; Das S; Gulati A
J Pharm Pharmacol; 1988 Jan; 40(1):70-2. PubMed ID: 2896784
[TBL] [Abstract][Full Text] [Related]
6. Modulation of mu, delta and kappa opioid receptors in rat brain by metal ions and histidine.
Tejwani GA; Hanissian SH
Neuropharmacology; 1990 May; 29(5):445-52. PubMed ID: 2162496
[TBL] [Abstract][Full Text] [Related]
7. (+)-[3H]SKF 10,047, (+)-[3H]ethylketocyclazocine, mu, kappa, delta and phencyclidine binding sites in guinea pig brain membranes.
Tam SW
Eur J Pharmacol; 1985 Feb; 109(1):33-41. PubMed ID: 2986989
[TBL] [Abstract][Full Text] [Related]
8. Mu opiate receptors are selectively labelled by [3H]carfentanil in human and rat brain.
Titeler M; Lyon RA; Kuhar MJ; Frost JF; Dannals RF; Leonhardt S; Bullock A; Rydelek LT; Price DL; Struble RG
Eur J Pharmacol; 1989 Aug; 167(2):221-8. PubMed ID: 2556284
[TBL] [Abstract][Full Text] [Related]
9. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
Tam SW; Liu-Chen LY
J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954
[TBL] [Abstract][Full Text] [Related]
10. Modulation of mu, kappa and delta opioid receptors in the rat brain by isoflurane and enflurane.
Tejwani GA; Rattan AK; Gudehithlu KP; McDonald JS
Neuropharmacology; 1991 Jun; 30(6):643-9. PubMed ID: 1656304
[TBL] [Abstract][Full Text] [Related]
11. Benzodiazepine interactions with central thyroid-releasing hormone binding sites: characterization and physiological significance.
Rinehart RK; Barbaz B; Iyengar S; Ambrose F; Steel DJ; Neale RF; Petrack B; Bittiger H; Wood PL; Williams M
J Pharmacol Exp Ther; 1986 Jul; 238(1):178-85. PubMed ID: 3014114
[TBL] [Abstract][Full Text] [Related]
12. Selective proliferation of brain kappa opiate receptors in spontaneously hypertensive rats.
Bhargava HN; Das S
Life Sci; 1986 Dec; 39(26):2593-600. PubMed ID: 3025539
[TBL] [Abstract][Full Text] [Related]
13. Sodium ions modulate differentially the effect of a benzodiazepine agonist on rat spinal mu-, delta- and kappa-opioid receptors.
Rattan AK; Tejwani GA
Pharmacology; 1994 Jan; 48(1):30-40. PubMed ID: 8309985
[TBL] [Abstract][Full Text] [Related]
14. A novel substance P binding site in rat brain regions modulates TRH receptor binding.
Sharif NA
Neurochem Res; 1990 Oct; 15(10):1045-9. PubMed ID: 1706485
[TBL] [Abstract][Full Text] [Related]
15. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
Meunier JC; Kouakou Y; Puget A; Moisand C
Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
[TBL] [Abstract][Full Text] [Related]
16. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe.
Stojilković SS; Dufau ML; Catt KJ
Endocrinology; 1987 Jul; 121(1):384-94. PubMed ID: 3036471
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of the binding of 3H-(3-MeHis2) thyrotropin releasing hormone to rat amygdala membranes by some naturally occurring cannabinoids.
Bhargava HN; Gulati A
Peptides; 1988; 9(4):771-5. PubMed ID: 2852360
[TBL] [Abstract][Full Text] [Related]
18. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
[TBL] [Abstract][Full Text] [Related]
19. The binding of 3H-(3-MeHis2) thyrotropin releasing hormone to brain and pituitary membranes of morphine tolerant-dependent and abstinent rats.
Bhargava HN; Das S; Bansinath M; Prasad R
Pharmacol Biochem Behav; 1989 Sep; 34(1):7-12. PubMed ID: 2516632
[TBL] [Abstract][Full Text] [Related]
20. Interaction between [3H]ethylketocyclazocine and [3H]etorphine and opioid receptors in membranes from rat brain. A kinetic analysis.
Fischel SV; Medzihradsky F
Neuropharmacology; 1986 Apr; 25(4):351-9. PubMed ID: 3012397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
